Related factors of new atrial high frequency events after cardiac electronic device implantation
-
摘要: 植入心脏植入式电子设备可以检测心房高频事件发生，也可以增加心房高频事件的发病率。心房高频事件与卒中的风险增加相关，但是关于早期识别心房高频事件的危险因素或预测因子的相关研究较少，使得我们不能尽早评估和干预卒中高风险人群，进而减少急性脑卒中事件的发生。本文从心房高频事件的定义、发病率和术后新发心房高频事件的相关因素等方面进行综述，以期为早期识别术后心房高频事件高危患者提供理论支持。Abstract: Implantation of cardiac implantable electronic devices can detect the occurrence of atrial high rate events, and can also increase the incidence rate of atrial high rate events. Atrial high rate events are associated with an increased risk of stroke, but there is limited research on early identification of risk factors or predictive factors for atrial high rate events, making it difficult to assess and intervene in high-risk stroke populations as early as possible, thereby reducing the occurrence of acute stroke events. This article reviews the definition of atrial high rate events, incidence rate and related factors of new atrial high rate events after surgery, in order to provide theoretical support for early identification of high-risk patients with atrial high rate events after surgery.
-
-
[1] 干琴静, 邱原刚. 心房颤动与肺血栓栓塞因果关系及抗凝治疗[J]. 临床心血管病杂志, 2022, 38(9): 752-755. https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2022.09.014
[2] Simu G, Rosu R, Cismaru G, et al. Atrial high-rate episodes: a comprehensive review[J]. Cardiovasc J Afr, 2021, 32(2): 102-107.
[3] Kashou AH, Adedinsewo DA, Noseworthy PA. Subclinical atrial fibrillation: a silent threat with uncertain implications[J]. Annu Rev Med, 2022, 73: 355-362. doi: 10.1146/annurev-med-042420-105906
[4] Khan AA, Boriani G, Lip G. Are atrial high rate episodes(AHREs)a precursor to atrial fibrillation?[J]. Clin Res Cardiol, 2020, 109(4): 409-416. doi: 10.1007/s00392-019-01545-4
[5] Doundoulakis I, Gavriilaki M, Tsiachris D, et al. Atrial high-rate episodes in patients with devices without a history of atrial fibrillation: a systematic review and meta-analysis[J]. Cardiovasc Drugs Ther, 2022, 36(5): 951-958. doi: 10.1007/s10557-021-07209-8
[6] 邹仕英, 王聪, 严冲, 等. 心房颤动患者血清NLRC4/Caspase-1表达及临床意义[J]. 临床心血管病杂志, 2022, 38(12): 988-993. https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2022.12.011
[7] Pastori D, Miyazawa K, Li Y, et al. Inflammation and the risk of atrial high-rate episodes(AHREs)in patients with cardiac implantable electronic devices[J]. Clin Res Cardiol, 2018, 107(9): 772-777. doi: 10.1007/s00392-018-1244-0
[8] Mathen PG, Chase D. Pacemaker detected prolonged atrial high rate episodes-Incidence, predictors and implications; a retrospective observational study[J]. J Saudi Heart Assoc, 2020, 32(2): 157-165. doi: 10.37616/2212-5043.1064
[9] Mkoko P, Chin A. Atrial high-rates episodes: fact or fiction?[J]. Cardiovasc J Afr, 2021, 32(2): 59-61.
[10] Benezet-Mazuecos J, Rosado AL, Crosa J, et al. Atrial high-rate episodes, subclinical atrial fibrillation and short-duration clinical atrial fibrillation: different names for the same arrhythmia or a new player on the pitch?[J]. J Saudi Heart Assoc, 2020, 32(2): 295-297. doi: 10.37616/2212-5043.1119
[11] Hindricks G, Potpara T, Dagres N, et al. Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC)Developed with the special contribution of the European Heart Rhythm Association(EHRA)of the ESC[J]. Eur Heart J, 2021, 42(40): 4194. doi: 10.1093/eurheartj/ehab648
[12] 李嘉欣, 鞠辉, 冯艺, 等. 术后房颤危险因素的研究进展[J]. 临床麻醉学杂志, 2022, 38(4): 432-435. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMZ202204019.htm
[13] Chen JH, Chen GY, Zheng H, et al. Atrial high-rate event incidence and predictors in patients with permanent pacemaker implantation[J]. Front Cardiovasc Med, 2021, 8: 728885. doi: 10.3389/fcvm.2021.728885
[14] Banerjee S, Majumdar S, Konar A. Prevalence of atrial high-rate episodes and the risk factors in Indian patients with cardiac implantable electronic devices: Real-world data[J]. J Arrhythm, 2019, 35(6): 830-835. doi: 10.1002/joa3.12239
[15] Liao MT, Chen CK, Lin TT, et al. High-sensitivity C-reactive protein is a predictor of subsequent atrial high-rate episodes in patients with pacemakers and preserved ejection fraction[J]. J Clin Med, 2020, 9(11): 3677. doi: 10.3390/jcm9113677
[16] Tekkeşin A, Velibey Y, Türkkan C, et al. Diastolic electrocardiographic parameters predict implantable device detected asymptomatic atrial fibrillation[J]. Balkan Med J, 2017, 34(5): 417-424. doi: 10.4274/balkanmedj.2016.0246
[17] Hwang TH, Yu HT, Kim TH, et al. Permanent pacemaker implantations after catheter ablation in patients with atrial fibrillation associated with underlying sinus node dysfunction[J]. Korean Circ J, 2020, 50(4): 346-357. doi: 10.4070/kcj.2019.0268
[18] Patel K, Reddy RK, Sau A, et al. Obesity as a risk factor for cardiac arrhythmias[J]. BMJ Med, 2022, 1(1): e000308. doi: 10.1136/bmjmed-2022-000308
[19] Fossier L, Panel M, Butruille L, et al. Enhanced mitochondrial calcium uptake suppresses atrial fibrillation associated with metabolic syndrome[J]. J Am Coll Cardiol, 2022, 80(23): 2205-2219. doi: 10.1016/j.jacc.2022.09.041
[20] Miyazawa K, Pastori D, Martin DT, et al. Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices[J]. Europace, 2022, 24(3): 375-383. doi: 10.1093/europace/euab186
[21] Uǧurlu M, Kaypakli O, Şahin DY, et al. Subclinical atrial fibrillation frequency and associated parameters in patients with cardiac resynchronization therapy[J]. J Interv Card Electrophysiol, 2018, 52(2): 217-223. doi: 10.1007/s10840-018-0385-4
[22] Wu Z, Chen X, Ge J, et al. The risk factors of new-onset atrial fibrillation after pacemaker implantation[J]. Herz, 2021, 46(Suppl 1): 61-68.
[23] Xu C, Chen K, Yu F, et al. Atrial Dyssynchrony: a new predictor for atrial high-rate episodes in patients with cardiac resynchronization therapy[J]. Cardiology, 2019, 144(1-2): 18-26. doi: 10.1159/000502541
[24] Nishinarita R, Niwano S, Oikawa J, et al. Novel predictor for new-onset atrial high-rate episode in patients with a dual-chamber pacemaker[J]. Circ Rep, 2021, 3(9): 497-503. doi: 10.1253/circrep.CR-21-0096
[25] Rubio Campal JM, Benezet-Mazuecos J, Iglesias Bravo JA, et al. P-wave and interatrial block: New predictor for atrial high rate episodes in patients with cardiac implantable electronic devices[J]. Pacing Clin Electrophysiol, 2018, 41(3): 223-228. doi: 10.1111/pace.13268
[26] Campal J, Arjona AS, Talavera C, et al. Paced P-wave duration as a significant predictor for atrial high-rate episodes in patients with cardiac implantable electronic devices[J]. Pacing Clin Electrophysiol, 2022, 45(7): 832-838. doi: 10.1111/pace.14541
[27] Satilmis S. Role of the monocyte-to-high-density lipoprotein ratio in predicting atrial high-rate episodes detected by cardiac implantable electronic devices[J]. North Clin Istanb, 2018, 5(2): 96-101.
[28] Wang S, Wei Y, Hidru TH, et al. Combined effect of homocysteine and uric acid to identify patients with high risk for subclinical atrial fibrillation[J]. J Am Heart Assoc, 2022, 11(1): e021997. doi: 10.1161/JAHA.121.021997
[29] Aksan G, Yanık A, Yontar OC, et al. Galectin-3 levels and the prediction of atrial high-rate episodes in patients with cardiac resynchronization therapy[J]. J Investig Med, 2021, 69(1): 20-27. doi: 10.1136/jim-2020-001459
[30] 宋雪城, 吉立双, 马芳芳, 等. 单核细胞计数与高密度脂蛋白胆固醇比值对患者双腔起搏器植入术后新发心房高频事件的预测价值[J]. 第二军医大学学报, 2021, 42(1): 41-47. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD202101008.htm
[31] Wakula P, Neumann B, Kienemund J, et al. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation[J]. Europace, 2017, 19(4): 544-551.
[32] Wakula P, Heinzel FR. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high rate episodes and paroxysmal atrial fibrillation: the role of TIMP-4 regulation-Authors' reply[J]. Europace, 2018, 20(7): 1229-1230.
[33] Rovaris G, Solimene F, D'Onofrio A, et al. Does the CHA2DS2-VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devices[J]. Heart Rhythm, 2018, 15(7): 971-979. doi: 10.1016/j.hrthm.2018.02.023
[34] Chen JY, Chen TW, Lu WD. The performance of five models compared with atrial high rate episodes predicts new atrial fibrillation after cardiac implantable electronic devices implantation[J]. Ann Noninvasive Electrocardiol, 2022, 27(5): e12978. doi: 10.1111/anec.12978
[35] El-Dosouky Ⅱ, Ammar AS, El Sherbiny IA, et al. Can we explore AF-pacemakers' relationship using clinical and echocardiographic parameters in patients with permanent pacemaker?(Echocardiography and subclinical AF in permanent pacemaker)[J]. Int J Cardiovasc Imaging, 2023, 39(2): 287-293.
[36] 陈康玉, 严激, 苏浩, 等. 左心室四极导线对心脏再同步化治疗后心房高频事件的影响[J]. 中国循环杂志, 2019, 34(8): 777-782. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH201908010.htm
[37] Zecchin M, Solimene F, D'Onofrio A, et al. Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissions[J]. J Arrhythm, 2020, 36(2): 353-362. doi: 10.1002/joa3.12319
[38] Samuel J, Batta A, Barwad P, et al. Incidence of atrial high rate episodes after dual-chamber permanent pacemaker implantation and its clinical predictors[J]. Indian Heart J, 2022, 74(6): 500-504. doi: 10.1016/j.ihj.2022.11.013
[39] Mittal S, Stein K, Gilliam FR 3rd, et al. Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation[J]. Am J Cardiol, 2008, 102(4): 450-453. doi: 10.1016/j.amjcard.2008.03.080
[40] Chen YL, Chuang JH, Wang HT, et al. Altered expression of circadian clock genes in patients with atrial fibrillation is associated with atrial high-rate episodes and left atrial remodeling[J]. Diagnostics(Basel), 2021, 11(1): 90.
[41] Krishnamoorthy S, Khoo CW, Lim HS, et al. Predictive value of atrial high-rate episodes for arterial stiffness and endothelial dysfunction in dual-chamber pacemaker patients[J]. Eur J Clin Invest, 2014, 44(1): 13-21. doi: 10.1111/eci.12182
[42] Huang SH, Liao CF, Chen ZY, et al. Distinct atrial remodeling in patients with subclinical atrial fibrillation: Lessons from computed tomographic images[J]. Pharmacol Res Perspect, 2022, 10(2): e00927. doi: 10.1002/prp2.927
-
计量
- 文章访问数: 678
- PDF下载数: 61
- 施引文献: 0
下载: